市場調査レポート
商品コード
1451231
瘢痕治療市場レポート:製品タイプ別、瘢痕タイプ別、エンドユーザー別、地域別、2024-2032Scar Treatment Market Report by Product or Treatment Type, Scar Type, End-User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
瘢痕治療市場レポート:製品タイプ別、瘢痕タイプ別、エンドユーザー別、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
|
世界の瘢痕治療市場規模は2023年に155億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて7.1%の成長率(CAGR)を示し、2032年までに292億米ドルに達すると予測しています。同市場は、大衆の美意識の高まり、顔の特徴を強調するための美容整形手術の採用増加、事故や傷害の発生件数の増加などを背景に、着実な成長を遂げています。
市場の成長と規模瘢痕治療市場は、外見重視の高まり、医療の進歩、多様な治療オプションなどを背景に、緩やかな成長を遂げています。
主な市場促進要因:再生医療などの医療技術の進歩は、効果的な瘢痕縮小ソリューションを提供する主要な促進要因です。医療と美容の両面における瘢痕治療サービスに対する需要の高まりと、皮膚外傷や傷害の蔓延が市場成長を後押ししています。
技術の進歩:レーザー技術や高度な局所製品など、瘢痕治療における継続的な技術革新が患者の治療成績を向上させ、市場拡大の原動力となっています。
主要市場動向:動向としては、非侵襲的瘢痕治療、特に局所製品や表面治療への関心の高まり、ダウンタイムの最小化と利便性への嗜好などが挙げられます。
地域別動向:北米が市場を独占しており、これは高度なヘルスケア・インフラと美容施術の隆盛に支えられています。しかし、アジア太平洋地域は、認知度の向上、ヘルスケア投資、美容整形手術の人気上昇により、急成長市場として浮上しています。
競合情勢:主なプレーヤーは、革新的な瘢痕治療ソリューションを導入し、世界のリーチを拡大するために研究開発(R&D)に投資しています。ヘルスケアプロバイダーとクリニックは、アクセシビリティと市場での存在感を高めるために協力しています。
課題と機会:課題としては、治療の選択肢が限られている瘢痕の種類に対応するための継続的な調査の必要性や、高度な瘢痕治療の手頃な価格などが挙げられます。とはいえ、特に新興国市場における瘢痕縮小サービスに対する需要の高まりに対応する機会や、より幅広い患者層に対応する費用対効果の高いソリューションの開拓により、これらの課題を克服できると予測されます。
医療技術の進歩
医療技術の継続的な進歩が市場の成長を促しています。これとは別に、瘢痕治療の選択肢に大きな変革が起きており、その結果、有効性が高まり、侵襲性が低下しています。特筆すべきブレークスルーはレーザー治療の普及です。レーザー技術は、精密で制御された低侵襲の処置を提供することで、瘢痕治療に革命をもたらしています。レーザーは瘢痕組織を極めて正確に狙い撃ちし、コラーゲンの生成を促し、瘢痕の見た目を著しく目立たなくすることができます。この技術革新は、患者の治療成績を向上させるだけでなく、ダウンタイムや不快感も軽減しています。さらに、マイクロダーマブレージョンの技術革新により、瘢痕を目立たなくするための非外科的な選択肢も患者に提供されつつあります。これらの処置は皮膚の表層を穏やかに剥離し、瘢痕の目立ちを減少させ、全体的な肌の質感を向上させる。フラクショナル・レーザー治療や高周波ベースの機器など、先進的な皮膚リサーフェシング技術の出現は、瘢痕治療の選択肢の幅を広げています。シリコーンジェルシートは、瘢痕管理におけるもう一つの重要な技術的進歩です。シリコンを主成分とする化合物を配合したこれらのシートは、瘢痕を平らにして柔らかくし、目立たなくするように設計されています。
美容施術への需要の高まり
自然な顔立ちや体型を改善する美容施術の人気が大衆の間で高まっており、市場の見通しが良好です。さらに、イメージ主導の社会では、個人は外見を重視し、完璧な肌を目指します。このような文化的変化は、医療上の必要性だけでなく、美容上の動機から、瘢痕治療への関心の高まりにつながっています。手術、事故、にきびなどによる傷跡を持つ人の大部分は、自尊心や自信を高めるために傷跡の除去や縮小治療を求めています。瘢痕治療処置は、全体的な外観を向上させ、平常心を取り戻す機会を提供します。このような顧客層の拡大は、効果的で痛みの少ない瘢痕治療への需要を促進し、美の基準の進化と、自己イメージや生活の質を向上させる治療に投資する人々の意欲を浮き彫りにしています。
皮膚外傷と傷害の多発
瘢痕治療に対する需要は、皮膚外傷や傷害の継続的な蔓延が原動力となっています。事故、火傷、外科的処置、様々な病状により、目に見える瘢痕を持つ人の数は増加の一途をたどっています。瘢痕治療は、このような患者の多くにとって、回復過程において不可欠な役割を果たしています。特に外科的切開は傷跡を残すことが多く、医療処置が進歩し、より身近になるにつれ、効果的な瘢痕治療の必要性は揺るぎないものとなっています。さらに、些細な事故から大きな事件まで、事故や怪我の発生により、専門的な瘢痕治療サービスを求める患者が後を絶たないです。瘢痕治療市場は、瘢痕に悩まされる人々の肉体的・精神的な幸福に貢献します。その成長は、皮膚外傷や傷害の継続的な発生と本質的に結びついており、ヘルスケア産業において回復力のある不可欠な分野となっています。革新的な治療法の継続的開拓により、この市場はさらなる拡大と患者の転帰の改善に向けて好位置にあります。
The global scar treatment market size reached US$ 15.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 29.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032. The market is experiencing steady growth driven by the heightened beauty consciousness among the masses, increasing adoption of cosmetic surgery to enhance facial features, and rising occurrence of accidents and injuries.
Market Growth and Size: The scar treatment market is experiencing moderate growth, on account of the increasing emphasis on physical appearance, medical advancements, and a diverse range of treatment options.
Major Market Drivers: Advancements in medical technology, such as regenerative medicine, are key drivers offering effective scar reduction solutions. The rising demand for scar treatment services for both medical and cosmetic purposes, as well as the prevalence of skin trauma and injuries, propels market growth.
Technological Advancements: Ongoing technological innovations in scar treatment, including laser technology and advanced topical products, are enhancing patient outcomes and driving market expansion.
Key Market Trends: Trends include the growing interest in non-invasive scar treatments, especially topical products and surface treatments, and preferences for minimal downtime and convenience.
Geographical Trends: North America dominates the market, supported by advanced healthcare infrastructure and the prominence of cosmetic procedures. However, Asia Pacific is emerging as a fast-growing market on account of the increasing awareness, healthcare investments, and the rising popularity of cosmetic surgeries.
Competitive Landscape: Key players are investing in research and development (R&D) to introduce innovative scar treatment solutions and expand their global reach. Healthcare providers and clinics are collaborating to enhance accessibility and market presence.
Challenges and Opportunities: Challenges include the need for continuous research to address scar types with limited treatment options and the affordability of advanced scar treatments. Nonetheless, opportunities for catering to the growing demand for scar reduction services, particularly in emerging markets, and developing cost-effective solutions to reach a wider patient base are projected to overcome these challenges.
Advancements in medical technology
The continuous advancement in medical technology is impelling the growth of the market. Apart from this, there is a profound transformation in scar treatment options, resulting in increased efficacy and reduced invasiveness. A notable breakthrough is the widespread adoption of laser therapy. Laser technology is revolutionizing scar treatment by providing precise, controlled, and minimally invasive procedures. It can target scar tissue with exceptional precision, stimulating collagen production and significantly diminishing the appearance of scars. This innovation is not only improving patient outcomes but also reducing downtime and discomfort. Furthermore, innovations in microdermabrasion techniques are providing patients with non-surgical alternatives for scar reduction. These procedures gently exfoliate the top layer of the skin, diminishing scar prominence and enhancing overall skin texture. The emergence of advanced skin resurfacing technologies, like fractional laser treatments and radiofrequency-based devices, is expanding the scope of scar treatment options. Silicone gel sheets are another significant technological advancement in scar management. These sheets, enriched with silicone-based compounds, are designed to flatten and soften scars, making them less conspicuous.
Rising demand for aesthetic procedures
The growing popularity of aesthetic procedures to improve natural facial features or body aspects among the masses is offering a favorable market outlook. Moreover, in an image-driven society, individuals place a premium on physical appearance and aspire to achieve flawless skin. This cultural shift is leading to a heightened interest in scar treatment procedures, driven not only by medical necessity but also by cosmetic motivations. A significant portion of individuals with scars, whether resulting from surgeries, accidents, or acne, seek scar removal or reduction treatments to boost their self-esteem and confidence. Scar treatment procedures offer them an opportunity to enhance their overall appearance and regain a sense of normalcy. This expanding customer base is driving the demand for effective and painless scar treatment, underscoring the evolving beauty standards and the willingness of people to invest in treatments that improve their self-image and quality of life.
Prevalence of skin trauma and injuries
The demand for scar treatment is driven by the ongoing prevalence of skin trauma and injuries. Accidents, burns, surgical procedures, and various medical conditions continually contribute to a greater number of individuals with visible scars. Scar treatment plays an indispensable role in the recovery process for many of these patients. Surgical incisions, in particular, frequently result in scars, and as medical procedures continue to advance and become more accessible, the need for effective scar treatment remains steadfast. Additionally, the occurrence of accidents and injuries, ranging from minor mishaps to major incidents, ensures a constant stream of patients seeking professional scar treatment services. The scar treatment market is instrumental in addressing both the physical and emotional well-being of individuals affected by scars. Its growth is intrinsically tied to the ongoing incidence of skin trauma and injuries, making it a resilient and indispensable segment within the healthcare industry. With the continued development of innovative treatments, the market is well-positioned for further expansion and improvement of patient outcomes.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product or treatment type, scar type, and end-user.
Topical Products
Gels
Creams
Oils
Sheets
Others
Laser Treatment
Surface Treatment
Injectables
Topical products account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product or treatment type. This includes topical products (gel, creams, oils, sheets, and others), laser treatment, surface treatment, and injectables. According to the report, topical products represented the largest segment.
Topical products represent the largest segment in the market. These products are widely favored for their ease of use and accessibility. They include scar gels, creams, oils, silicone gel sheets, and other formulations that can be applied directly to the scarred area. Topical products are popular due to their non-invasive nature and the fact that patients can administer them at home. They work by hydrating and softening scar tissue, which can significantly improve the appearance of scars over time. The market for topical scar treatments continues to expand with ongoing product innovations and a growing consumer preference for non-surgical options.
Laser therapy involves the use of laser technology to target scar tissue beneath the surface of the skin. Lasers can precisely stimulate collagen production, reducing the appearance of scars. This method is appreciated for its effectiveness and minimal downtime, making it a preferred choice for those seeking faster results with minimal invasiveness. Laser treatment remains in demand due to its ability to treat a variety of scar types, including acne scars and surgical scars.
Surface treatments encompass a range of procedures like microdermabrasion, chemical peels, and dermabrasion that focus on the top layer of the skin. These treatments exfoliate and resurface the skin, which can lead to a reduction in the appearance of scars. Surface treatments are valued for their ability to improve skin texture and are often chosen for scars that are closer to the surface of the skin or for patients looking for a less invasive option.
Injectables involve the use of substances like corticosteroids or hyaluronic acid to treat certain types of scars, particularly hypertrophic and keloid scars. They work by reducing inflammation and promoting collagen remodeling. They provide a valuable option for specific scar types that may not respond as effectively to other treatments.
Atrophic Scars
Hypertrophic And Keloid Scars
Contracture Scars
Others
Atrophic scars hold the largest share in the industry
A detailed breakup and analysis of the market based on the scar type have also been provided in the report. This includes atrophic scars, hypertrophic and keloid scars, contracture scars, and others. According to the report, atrophic scars accounted for the largest market share.
Atrophic scars are characterized by a loss of skin tissue and are commonly associated with conditions like acne or chickenpox. The market for atrophic scar treatment includes various modalities, such as topical products, laser therapy, and dermal fillers. Topical products like creams and gels are often used to improve skin texture and stimulate collagen production, making them a popular choice for addressing atrophic scars. Laser therapy can also be effective in promoting collagen remodeling, which can help reduce the depth and visibility of atrophic scars. The demand for treatments addressing atrophic scars is driven by the desire for smoother, more even skin texture.
The hypertrophic and keloid scars are characterized by excess collagen production, leading to raised and often itchy or painful scar tissue. Treatment options for hypertrophic and keloid scars typically include topical products, corticosteroid injections, laser therapy, and surgical excision. Corticosteroid injections can help flatten and soften these scars, while laser therapy can reduce the redness and discomfort associated with them. The demand for treatments targeting hypertrophic and keloid scars is fueled by the need to alleviate physical discomfort and improve the appearance of raised scars.
Contracture scars are caused by burns or injuries that result in skin tightening and restricted movement. Treatment options for contracture scares include surgical scar revision, laser therapy, and physical therapy. Surgical scar revision can help release tight bands of scar tissue, restoring range of motion and improving the appearance of the scar. The demand for contracture scar treatments is driven by the desire to enhance both physical function and aesthetics, particularly in cases where scars impede movement.
Hospitals
Clinics
Retail Pharmacies
Others
Hospitals represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals, clinics, retail pharmacies, and others. According to the report, hospitals represented the largest segment.
Hospitals constitute the largest segment as they are crucial in scar treatment, particularly for patients with severe or complex scars resulting from surgeries, accidents, or burns. Hospitals have access to advanced medical equipment, surgical facilities, and a team of specialized healthcare professionals, making them well-equipped to offer comprehensive scar treatment services. These services often include surgical scar revision, laser therapy, and other advanced procedures.
Clinics offer outpatient services for scar treatment, catering to individuals with less severe or more common scar issues. Clinics can provide treatments, such as topical products, surface treatments like microdermabrasion or chemical peels, and injectable therapies. Patients often prefer clinics for their convenience, shorter waiting times, and accessibility.
Retail pharmacies offer over-the-counter (OTC) scar treatment products, such as creams, gels, and silicone sheets. While they do not provide specialized medical procedures, retail pharmacies play a crucial role in making scar treatment products readily available to consumers. Many individuals with minor scars prefer to start with OTC products, and retail pharmacies cater to this market segment by offering a wide variety of scar treatment options.
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
North America leads the market, accounting for the largest scar treatment market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, and others); and the Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, and others). According to the report, North America accounted for the largest market share.
The North America scar treatment market is driven by the existence of advanced healthcare infrastructure, including state-of-the-art medical facilities and skilled healthcare professionals. This infrastructure enables the adoption of cutting-edge scar treatment technologies and attracts patients seeking high-quality care.
Asia Pacific maintains a strong presence driven by the growing availability of cost-effective scar treatment options. This trend is driving international patients to seek affordable yet quality scar treatment services.
Europe stands as another key region in the market, driven by the strong focus on technological advancements in scar treatment. Innovative therapies, such as fractional laser treatments and regenerative medicine approaches, are gaining traction, attracting both patients and investors.
Latin America exhibits growing potential in the scar treatment market, fueled by the growing demand for scar treatments, especially among individuals seeking to enhance their physical appearance.
The Middle East and Africa region show a developing market for scar treatment, driven by the increasing incidences of conditions like hypertrophic and keloid scars, often related to skin pigmentation and genetics among the masses.
The key players in the scar treatment market are actively engaged in various strategic initiatives to maintain and expand their market presence. These initiatives include research and development (R&D) efforts to introduce innovative scar treatment technologies and products, such as advanced laser therapies and regenerative medicine approaches. Additionally, major players are focusing on geographical expansion, entering emerging markets, where the demand for scar treatment services is growing. Marketing and promotional activities to raise awareness among consumers about the benefits of scar treatment are also a priority. Furthermore, partnerships and collaborations with healthcare providers and clinics are being forged to enhance the accessibility of scar treatment services. Overall, top companies are committed to meeting the evolving needs of patients and maintaining their positions as leaders in the scar treatment industry.
Alliance Pharma PLC
AVITA Medical Ltd.
Bausch Health Companies Inc.
Cutera, Inc.
Establishment Labs SA
GC Aesthetics PLC
Hologic Inc.
Molnlycke Health Care AB
Smith & Nephew PLC
Sonoma Pharmaceuticals Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
March 2022: Alliance Pharma PLC announced the acquisition of silicone-based scar treatment brand ScarAway in the US to expand its consumer base.
September 2023: Cutera Inc. announced the launch of Secret DUO, an innovative skin resurfacing and revitalization platform that utilizes dual non-ablative fractional technologies.